Skip to main content

Advertisement

SpringerLink
Log in

Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients

  • Letter to the Editor
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Gastric cancer (GC) is the second highest cause of cancer mortality worldwide. However, nowadays, most of the studies aiming to understand the gastric carcinogenesis analyzed tumors of individuals from Asian population and, thus, may not reflect the distinct biological and clinical behaviors among GC processes. Since several membrane proteins have been implicated in carcinogenesis, we aimed to evaluate ANXA2 and GAL3 role in gastric tumors and GC cell lines of individuals from northern Brazil. The cellular localization of ANXA2 and GAL3 in the GC cell lines was evaluated by immunofluorescence. Gene expression was evaluated by real-time reverse-transcription PCR and protein expression by Western blot in gastric adenocarcinomas and non-neoplastic gastric samples, as well as in GC cell lines. ANXA2 and GAL3 were presented as dots in the plasma membrane and cytoplasm in ACP02 and ACP03 cell lines. ANXA2 mRNA expression was up-regulated in 32.14 % of gastric tumors compared to non-neoplastic tissues. ANXA2 up-regulation was associated with the metastasis process in vivo and with cell line invasive behavior. GAL3 protein expression was at least 1.5-fold reduced in 50 % of gastric tumors. The reduced GAL3 expression was associated with the presence of distant metastasis and with a higher invasive phenotype in vitro. Our study shows that ANXA2 and GAL3 deregulated expression was associated with an invasive phenotype in GC cell lines and may contribute to metastasis in GC patients. Therefore, these proteins may have potential prognostic relevance for GC of individuals from northern Brazil.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  2. Shah MA, Ajani JA. Gastric cancer—an enigmatic and heterogeneous disease. JAMA. 2010;303:1753–4. doi:10.1001/jama.2010.553.

    Article  CAS  PubMed  Google Scholar 

  3. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354–62.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Adam PJ, Boyd R, Tyson KL, et al. Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J Biol Chem. 2003;278:6482–9. doi:10.1074/jbc.M210184200.

    Article  CAS  PubMed  Google Scholar 

  5. Leal MF, Chung J, Calcagno DQ, Assumpcao PP, et al. Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil. PLoS One. 2012;7:e42255. doi:10.1371/journal.pone.0042255PONE-D-11-08927.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Batista dos Santos SE, Rodrigues JD, Ribeiro-dos-Santos AK, Zago MA. Differential contribution of indigenous men and women to the formation of an urban population in the Amazon region as revealed by mtDNA and Y-DNA. Am J Phys Anthropol. 1999;109:175–80. doi:10.1002/(SICI)1096-8644(199906)109:2<175::AID-AJPA3>3.0.CO;2-%23.

    Article  CAS  PubMed  Google Scholar 

  7. Leal MF, Martins do Nascimento JL, da Silva CE, et al. Establishment and conventional cytogenetic characterization of three gastric cancer cell lines. Cancer Genet Cytogenet. 2009;195:85–91. doi:10.1016/j.cancergencyto.2009.04.020.

    Article  PubMed  Google Scholar 

  8. Leal MF, Calcagno DQ, Costa JFFB, et al. MYC, TP53, and chromosome 17 copy-number alterations in multiple gastric cancer cell lines and in their parental primary tumors. J Biomed Biotechnol. 2011;. doi:10.1155/2011/631268.

    PubMed  PubMed Central  Google Scholar 

  9. Calcagno DQ, Freitas VM, Leal MF, et al. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer. BMC Gastroenterol. 2013;13:141. doi:10.1186/1471-230X-13-141.

    Article  PubMed  PubMed Central  Google Scholar 

  10. da Costa Jde F, Leal MF, Silva TC, et al. Experimental gastric carcinogenesis in Cebus apella nonhuman primates. PLoS One. 2011;6:e21988. doi:10.1371/journal.pone.0021988PONE-D-11-03343.

    Article  Google Scholar 

  11. Guo T, Fan L, Ng WH, et al. Multidimensional identification of tissue biomarkers of gastric cancer. J Proteome Res. 2012;. doi:10.1021/pr300212g.

    Google Scholar 

  12. Hofmann A, Gerrits B, Schmidt A, et al. Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells. Blood. 2010;116:e26–34. doi:10.1182/blood-2010-02-271270.

    Article  CAS  PubMed  Google Scholar 

  13. Ponten F, Jirstrom K, Uhlen M. The human protein atlas—a tool for pathology. J Pathol. 2008;216:387–93. doi:10.1002/path.2440.

    Article  CAS  PubMed  Google Scholar 

  14. Leal MF, Mazzotti TK, Calcagno DQ, et al. Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications. BMC Gastroenterol. 2014;14:9. doi:10.1186/1471-230X-14-9.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Leal MF, Calcagno DQ, Demachki S, et al. Clinical implication of 14-3-3 epsilon expression in gastric cancer. World J Gastroenterol. 2012;18:1531–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Emoto K, Sawada H, Yamada Y, et al. Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res. 2001;21:1339–45.

    CAS  PubMed  Google Scholar 

  17. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev. 2002;82:331–71. doi:10.1152/physrev.00030.2001.

    Article  CAS  PubMed  Google Scholar 

  18. Filipenko NR, Waisman DM. The C terminus of annexin II mediates binding to F-actin. J Biol Chem. 2001;276:5310–5. doi:10.1074/jbc.M009710200.

    Article  CAS  PubMed  Google Scholar 

  19. Hansen MD, Ehrlich JS, Nelson WJ. Molecular mechanism for orienting membrane and actin dynamics to nascent cell–cell contacts in epithelial cells. J Biol Chem. 2002;277:45371–6. doi:10.1074/jbc.M207747200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Babbin BA, Parkos CA, Mandell KJ, et al. Annexin 2 regulates intestinal epithelial cell spreading and wound closure through Rho-related signaling. Am J Pathol. 2007;170:951–66. doi:10.2353/ajpath.2007.060647.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Dong WG, Yu QF, Xu Y, Fan LF. Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer. Dig Dis Sci. 2008;53:1811–7. doi:10.1007/s10620-007-0080-2.

    Article  CAS  PubMed  Google Scholar 

  22. Miyazaki J, Hokari R, Kato S, et al. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes. Oncol Rep. 2002;9:1307–12.

    CAS  PubMed  Google Scholar 

  23. Baldus SE, Zirbes TK, Weingarten M, et al. Increased galectin-3 expression in gastric cancer: correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation. Tumour Biol. 2000;21:258–66.

    Article  CAS  PubMed  Google Scholar 

  24. Okada K, Shimura T, Suehiro T, Mochiki E, Kuwano H. Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer. Anticancer Res. 2006;26:1369–76.

    CAS  PubMed  Google Scholar 

  25. Ellerhorst J, Troncoso P, Xu XC, Lee J, Lotan R. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer. Urol Res. 1999;27:362–7.

    Article  CAS  PubMed  Google Scholar 

  26. Pacis RA, Pilat MJ, Pienta KJ, et al. Decreased galectin-3 expression in prostate cancer. Prostate. 2000;44:118–23. doi:10.1002/1097-0045(20000701)44:2<118:AID-PROS4>3.0.CO;2-U.

    Article  CAS  PubMed  Google Scholar 

  27. van den Brule FA, Berchuck A, Bast RC, et al. Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur J Cancer. 1994;30A:1096–9.

    Article  PubMed  Google Scholar 

  28. Lotz MM, Andrews CW Jr, Korzelius CA, et al. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA. 1993;90:3466–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Choufani G, Nagy N, Saussez S, et al. The levels of expression of galectin-1, galectin-3, and the Thomsen–Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers. Cancer. 1999;86:2353–63.

    Article  CAS  PubMed  Google Scholar 

  30. Castronovo V, Van Den Brule FA, Jackers P, et al. Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol. 1996;179:43–8. doi:10.1002/(SICI)1096-9896(199605)179:1<43:AID-PATH541>3.0.CO;2-N.

    Article  CAS  PubMed  Google Scholar 

  31. de Oliveira JT, de Matos AJ, Gomes J, et al. Coordinated expression of galectin-3 and galectin-3-binding sites in malignant mammary tumors: implications for tumor metastasis. Glycobiology. 2010;20:1341–52. doi:10.1093/glycob/cwq103.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq; RC, MACS and RRB) and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP; MFL, JC and DQC) as grants and fellowship awards. We acknowledge the Mass Spectrometry Laboratory at Brazilian Biosciences National Laboratory, CNPEM-ABTLuS, Campinas, Brazil and Dr. Adriana F. Paes Leme and technicians for their assistance with the mass spectrometric analyses.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Disciplina de Genética, Departamento de Morfologia e Genética, Universidade Federal de São Paulo, R. Botucatu, 740, São Paulo, SP, CEP 04023-900, Brazil

    Mariana Ferreira Leal, Danielle Queiroz Calcagno & Marília Cardoso Smith

  2. Departamento de Ortopedia e Traumatologia, Universidade Federal de São Paulo, São Paulo, SP, 04038-031, Brazil

    Mariana Ferreira Leal

  3. Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo, São Paulo, SP, 04023-062, Brazil

    Janete Chung

  4. Laboratório de Biologia da Matriz Extracelular, Departamento de Biologia Celular e do Desenvolvimento, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, 05508-000, Brazil

    Vanessa Morais de Freitas

  5. Núcleo de Pesquisa em Oncologia, Hospital Universitário João de Barros Barreto, Universidade Federal do Pará, Belém, PA, 60673-000, Brazil

    Danielle Queiroz Calcagno, Samia Demachki & Paulo Pimentel Assumpção

  6. Laboratório de Oncologia Experimental, Departamento de Radiologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, 01246-903, Brazil

    Roger Chammas

  7. Centro de Investigação Translacional em Oncologia, Instituto do Câncer do Estado de São Paulo, São Paulo, SP, 01246-000, Brazil

    Roger Chammas

  8. Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, PA, 66073-000, Brazil

    Rommel Rodríguez Burbano

Authors
  1. Mariana Ferreira Leal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Danielle Queiroz Calcagno
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janete Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vanessa Morais de Freitas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Samia Demachki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paulo Pimentel Assumpção
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Roger Chammas
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rommel Rodríguez Burbano
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marília Cardoso Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mariana Ferreira Leal.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 455 kb)

Supplementary material 2 (XLS 456 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leal, M.F., Calcagno, D.Q., Chung, J. et al. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clin Exp Med 15, 415–420 (2015). https://doi.org/10.1007/s10238-014-0299-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-014-0299-0

Keywords

Search

Navigation